Atai Life Sciences Market Cap 2020-2023 | ATAI

Atai Life Sciences market cap history and chart from 2020 to 2023. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Atai Life Sciences market cap as of April 22, 2024 is $0.31B.
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.310B $0.000B
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $16.532B 10.00
Quest Diagnostics (DGX) United States $14.447B 14.94
DaVita (DVA) United States $11.622B 15.81
Chemed (CHE) United States $9.137B 28.75
Encompass Health (EHC) United States $8.044B 22.07
Elanco Animal Health (ELAN) United States $6.389B 14.53
Option Care Health (OPCH) United States $5.286B 20.69
RadNet (RDNT) United States $3.263B 95.30
Amedisys (AMED) United States $2.981B 21.27
LifeStance Health (LFST) United States $2.235B 0.00
Astrana Health (ASTH) United States $2.075B 26.17
Addus HomeCare (ADUS) United States $1.517B 23.26
U.S Physical Therapy (USPH) United States $1.506B 39.03
Pennant (PNTG) United States $0.626B 36.58
Aveanna Healthcare Holdings (AVAH) United States $0.437B 0.00
Daxor (DXR) United States $0.046B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.030B 0.00
ATI Physical Therapy (ATIP) United States $0.017B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Novo Integrated Sciences (NVOS) United States $0.010B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.004B 0.00